Shubhra Mace

589 total citations
14 papers, 467 citations indexed

About

Shubhra Mace is a scholar working on Psychiatry and Mental health, Neurology and Clinical Psychology. According to data from OpenAlex, Shubhra Mace has authored 14 papers receiving a total of 467 indexed citations (citations by other indexed papers that have themselves been cited), including 11 papers in Psychiatry and Mental health, 3 papers in Neurology and 3 papers in Clinical Psychology. Recurrent topics in Shubhra Mace's work include Schizophrenia research and treatment (10 papers), Bipolar Disorder and Treatment (3 papers) and Botulinum Toxin and Related Neurological Disorders (2 papers). Shubhra Mace is often cited by papers focused on Schizophrenia research and treatment (10 papers), Bipolar Disorder and Treatment (3 papers) and Botulinum Toxin and Related Neurological Disorders (2 papers). Shubhra Mace collaborates with scholars based in United Kingdom and United States. Shubhra Mace's co-authors include David Taylor, Eromona Whiskey, Maxine X. Patel, Corina Young, Ebenezer Oloyede, Olubanké Dzahini, Maria O’Hagan, Victoria Cornelius, David B. Anthony and Tom Walker‐Tilley and has published in prestigious journals such as SHILAP Revista de lepidopterología, The Journal of Clinical Psychiatry and Acta Psychiatrica Scandinavica.

In The Last Decade

Shubhra Mace

14 papers receiving 441 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Shubhra Mace United Kingdom 9 277 125 93 59 55 14 467
Pedro Such Denmark 11 307 1.1× 135 1.1× 73 0.8× 52 0.9× 40 0.7× 32 486
I. Kurzthaler Austria 15 462 1.7× 126 1.0× 97 1.0× 34 0.6× 71 1.3× 31 704
Anna Sparshatt United Kingdom 13 405 1.5× 150 1.2× 77 0.8× 39 0.7× 82 1.5× 16 581
Anita S. Kablinger United States 14 216 0.8× 78 0.6× 133 1.4× 80 1.4× 44 0.8× 50 641
Michael D. Teehan Canada 12 312 1.1× 87 0.7× 119 1.3× 32 0.5× 68 1.2× 22 526
Ole Schjerning Denmark 9 285 1.0× 145 1.2× 72 0.8× 29 0.5× 44 0.8× 15 608
Nael Kilzieh United States 10 414 1.5× 87 0.7× 168 1.8× 32 0.5× 54 1.0× 16 561
Joseph Pultz United States 8 296 1.1× 85 0.7× 115 1.2× 88 1.5× 47 0.9× 11 526
N. Schooler United States 8 252 0.9× 115 0.9× 132 1.4× 70 1.2× 42 0.8× 18 517
Judy Hope Australia 10 286 1.0× 85 0.7× 108 1.2× 30 0.5× 50 0.9× 36 454

Countries citing papers authored by Shubhra Mace

Since Specialization
Citations

This map shows the geographic impact of Shubhra Mace's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Shubhra Mace with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Shubhra Mace more than expected).

Fields of papers citing papers by Shubhra Mace

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Shubhra Mace. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Shubhra Mace. The network helps show where Shubhra Mace may publish in the future.

Co-authorship network of co-authors of Shubhra Mace

This figure shows the co-authorship network connecting the top 25 collaborators of Shubhra Mace. A scholar is included among the top collaborators of Shubhra Mace based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Shubhra Mace. Shubhra Mace is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

14 of 14 papers shown
1.
Oloyede, Ebenezer, et al.. (2022). Clozapine augmentation with cariprazine for negative symptoms: a case series and literature review. SHILAP Revista de lepidopterología. 12. 1926983954–1926983954. 24 indexed citations
2.
Mace, Shubhra, et al.. (2022). Incident infection during the first year of treatment – A comparison of clozapine and paliperidone palmitate long-acting injection. Journal of Psychopharmacology. 36(2). 232–237. 6 indexed citations
3.
Reilly, Thomas J., et al.. (2021). Improving the management of menopause in women with serious mental illness. BJPsych Open. 7(S1). S185–S185. 1 indexed citations
4.
Mace, Shubhra, et al.. (2019). Positive views on antipsychotic long-acting injections: results of a survey of community patients prescribed antipsychotics. SHILAP Revista de lepidopterología. 9. 3627426545–3627426545. 14 indexed citations
5.
Mace, Shubhra, et al.. (2018). A prospective year-long follow-up of lurasidone use in clinical practice: factors predicting treatment persistence. Therapeutic Advances in Psychopharmacology. 8(4). 117–125. 7 indexed citations
6.
Mace, Shubhra, Olubanké Dzahini, Maria O’Hagan, & David Taylor. (2018). Haloperidol decanoate long-acting injection (HDLAI): Results of a 1-year mirror-image study. Therapeutic Advances in Psychopharmacology. 8(9). 241–249. 8 indexed citations
7.
Mace, Shubhra, Olubanké Dzahini, Victoria Cornelius, et al.. (2015). Antipsychotic use and unexpected death: a hospital-based case-control study. Acta Psychiatrica Scandinavica. 132(6). 479–488. 2 indexed citations
8.
Mace, Shubhra & David Taylor. (2014). Reducing the rates of prescribing high-dose antipsychotics and polypharmacy on psychiatric inpatient and intensive care units: results of a 6-year quality improvement programme. Therapeutic Advances in Psychopharmacology. 5(1). 4–12. 31 indexed citations
9.
Mace, Shubhra & David Taylor. (2011). Improving adherence to NICE guidance for bipolar illness: valproate use in women of childbearing potential. The Psychiatrist. 35(2). 63–67. 7 indexed citations
10.
Mace, Shubhra & David Taylor. (2009). Aripiprazole. CNS Drugs. 23(9). 773–780. 29 indexed citations
11.
Mace, Shubhra & David Taylor. (2005). A prescription survey of antipsychotic use in England and Wales following the introduction of NICE guidance. International Journal of Psychiatry in Clinical Practice. 9(2). 124–129. 12 indexed citations
12.
Taylor, David, Corina Young, Shubhra Mace, & Maxine X. Patel. (2004). Early Clinical Experience With Risperidone Long-Acting Injection. The Journal of Clinical Psychiatry. 65(8). 1076–1083. 47 indexed citations
13.
Taylor, David, et al.. (2002). Co-prescribing of atypical and typical antipsychotics – prescribing sequence and documented outcome. Psychiatric Bulletin. 26(5). 170–172. 33 indexed citations
14.
Mace, Shubhra & David Taylor. (2000). Selective serotonin reuptake inhibitors: a review of efficacy and tolerability in depression. Expert Opinion on Pharmacotherapy. 1(5). 917–933. 246 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Pedro Such Breakdown of academic impact, for papers by I. Kurzthaler Breakdown of academic impact, for papers by Anna Sparshatt Breakdown of academic impact, for papers by Anita S. Kablinger Breakdown of academic impact, for papers by Michael D. Teehan Breakdown of academic impact, for papers by Ole Schjerning Breakdown of academic impact, for papers by Nael Kilzieh Breakdown of academic impact, for papers by Joseph Pultz Breakdown of academic impact, for papers by N. Schooler Breakdown of academic impact, for papers by Judy Hope
Rankless by CCL
2026